EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY 4.0

Anti-contactin-1 autoimmune nodopathy with thymoma: case report and literature review

Takumi Tashiro, Hidenori Ogata, Motoi Kuwahara, Haruo Nishijima, Kenichiro Nogami, Takahiro Yamaguchi, Hitoshi Hayashida, Guzailiayi Maimaitijiang, Ryo Yamasaki, Jun-Ichi Kira, Yoshitaka Nagai, Noriko Isobe

Frontiers in Immunology · 2025

DOI: 10.3389/fimmu.2025.1662299 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Immunology, 2025. Verfasst von Takumi Tashiro und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Thymoma, Autoantibodies, Thymus Neoplasms, Contactin 1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Backgrounds Autoimmune nodopathies (ANs) with autoantibodies against cell adhesion molecules including contactin-1 (CNTN1) located in the nodes of Ranvier and paranodes have specific clinical features. Patients with anti-CNTN1 AN accompanied by paraneoplastic status have been reported. Here, we describe three patients with anti-CNTN1 AN and concurrent thymoma. In addition, we performed a literature review to investigate the relationship between demyelinating peripheral neuropathy and thymoma.

Methods

Serum CNTN1-IgG and IgG subclasses were measured by cell-based assay or enzyme-linked immunosorbent assay. Clinical, electrophysiological, and pathological data were obtained from the medical records of patients. CNTN1-IgG titers and serum neurofilament light chain (sNfL) were followed over the disease course. Through a literature survey of demyelinating peripheral neuropathy and thymoma, we summarized the clinical features and involvement of CNTN1-IgG.

Results

Three patients with CNTN1-IgG4 were elderly men, who presented with subacute disease progression, sensory ataxia, very high cerebrospinal fluid (CSF) protein levels, and apparent conduction delay in nerve conduction studies. In two patients with type B3 thymoma, thymectomy did not improve their neurological symptoms. In one case with type AB thymoma, nephrotic syndrome and pemphigus foliaceus appeared with the deterioration of neuropathy after thymectomy. All patients responded well to immunotherapies in parallel with decreased antibody titers and sNfL levels. Our literature survey identified a total of twelve cases, including our patients, of demyelinating peripheral neuropathy with thymoma. Ten were male and the mean age at onset was 57 years. Limb weakness and sensory ataxia were observed in 73% and 71% of patients, respectively. CSF protein levels were elevated in seven of nine patients. Four patients with Good’s syndrome or malignant thymoma progressed to death, whereas the other patients had a favorable response to mono- or combined immunotherapies. CNTN1-IgG was identified in four patients including those in this report.

Conclusion

Thymoma can be accompanied by anti-CNTN1 AN. Adequate immunotherapies should be considered regardless of the efficacy of thymectomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThymomaAutoantibodiesThymus NeoplasmsContactin 1HumansMaleMiddle AgedAgedImmunoglobulin GFemale

Stichwörter der Autor:innen

autoimmune nodopathybiomarkercontactin-1demyelinating neuropathythymoma

Substanzen

AutoantibodiesContactin 1CNTN1 protein, humanImmunoglobulin G

Autor:innen und Institutionen

  • Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Neurology, Kindai University Faculty of Medicine, Osaka, Japan.
  • Department of Neurology, Hirosaki University Hospital, Aomori, Japan.
  • Department of Neurology, National Hospital Organization Beppu Medical Center, Oita, Japan.
  • Division of Clinical Chemistry and Laboratory Medicine, Kyushu University Hospital, Fukuoka, Japan.
  • Translational Neuroscience Research Center, Graduate School of Medicine, International University of Health and Welfare, Fukuoka, Japan.

Zitieren

APA

Tashiro, T., Ogata, H., Kuwahara, M., Nishijima, H., Nogami, K., Yamaguchi, T., Hayashida, H., Maimaitijiang, G., Yamasaki, R., Kira, J. I., Nagai, Y., & Isobe, N. (2025). Anti-contactin-1 autoimmune nodopathy with thymoma: case report and literature review. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1662299

Vancouver

Tashiro T, Ogata H, Kuwahara M, Nishijima H, Nogami K, Yamaguchi T, et al. Anti-contactin-1 autoimmune nodopathy with thymoma: case report and literature review. Frontiers in Immunology. 2025. doi:10.3389/fimmu.2025.1662299

BibTeX
@article{Tashiro2025,
  author = {Tashiro, Takumi and Ogata, Hidenori and Kuwahara, Motoi and Nishijima, Haruo and Nogami, Kenichiro and Yamaguchi, Takahiro and Hayashida, Hitoshi and Maimaitijiang, Guzailiayi and Yamasaki, Ryo and Kira, Jun-Ichi and Nagai, Yoshitaka and Isobe, Noriko},
  title = {Anti-contactin-1 autoimmune nodopathy with thymoma: case report and literature review},
  journal = {Frontiers in Immunology},
  year = {2025},
  doi = {10.3389/fimmu.2025.1662299}
}
Kostenlos starten →